Independent medication information Not a pharmacy · Not a substitute for medical advice
Dissociatives / Medication and dissociative

Ketamine

Identity, uses and research, side effects, dosage context, pricing and online access.

Medication and dissociativeDissociativesSchedule III
Reference nameKetamine
Entry typeMedication and dissociative
CategoryDissociatives
Drug classDissociative anesthetic
Related moleculeEsketamine
Clinical distinctionAnesthesia versus psychiatric treatment

DrugRX editorial reference · Sources consulted · Not independently medically reviewed

Ketamine hydrochloride product, as identified by the source.

Ketamine hydrochloride product, as identified by the source.

Coaster420 · Public domain

About Ketamine

Ketamine is an anesthetic medicine. Esketamine, the active ingredient in Spravato, is related but distinct and has separate approved treatment requirements.

Also searched as: Special K · Ketalar

PRODUCT FORMULATIONS

Available strengths

Strength is the amount in a tablet, capsule, liquid or patch. Different formulations are listed separately.

Product & formulationStrengths
Ketamine hydrochloride
Injectable solution
10 mg/mL · 50 mg/mL · 100 mg/mL

Concentration is expressed as ketamine base. Anesthetic administration requires a clinical setting; concentration is not an administered dose.

Product label · Checked 2026-10-31
PRICE, COST & AVAILABILITY

Buy Ketamine: pricing & legal access

Ketamine online: availability & product information

Saved U.S. price estimates from Drugs.com for the exact products and quantities below. These are dated estimates, not live pharmacy quotes or insurance copays. Discounts and local availability vary.

Product / strengthQuantityPrice (USD)
Ketamine injection
100 mg/mL
Injectable solution
50 mL$54.02–$60.99
Drugs.com published cash estimate
Drugs.com price guide
Checked 2026-10-31

Prices refer to medication only; consultation, administration and monitoring costs may be additional. Prescription products require a valid prescription and a licensed pharmacy. Check the exact formulation before comparing offers.

DETAILED REFERENCE

Ketamine information

Ketamine versus esketamine

Ketamine has anesthetic uses. Compounded ketamine products used for psychiatric care are not FDA-approved psychiatric formulations. Spravato is administered through certified healthcare settings under a risk-management program.

Sources: CDC — Ketamine and esketamine facts (2026)

Risks and monitoring

Sedation, dissociation and respiratory concerns make medical oversight important. Unregulated sources add uncertainty about ingredients and strength.

Sources: CDC — Ketamine and esketamine facts (2026)

Dosing is formulation-specific

Injection, compounded oral products and esketamine nasal spray do not share interchangeable instructions. A clinician must determine eligibility and monitoring.

Sources: CDC — Ketamine and esketamine facts (2026)

Ketamine and esketamine

Ketamine and esketamine are related but different active-drug descriptions. Spravato is an esketamine nasal-spray product with specified clinical administration requirements; its approval does not extend to every compounded ketamine product.

Sources: CDC — Ketamine and esketamine facts (2026)

Clinical setting and monitoring

Anesthesia, a monitored psychiatric visit and unsupervised use are different settings. Sedation and altered awareness affect the need for observation and discharge planning. A product-only price cannot describe all of the services involved.

Sources: CDC — Ketamine and esketamine facts (2026)

What compounded means

Compounding produces a preparation for a particular clinical context. It is not the same approval pathway as an FDA-approved finished medicine, and it does not establish that another formulation has been evaluated for the same indication.

Sources: CDC — Ketamine and esketamine facts (2026)

Comparing treatment claims

Identify the active ingredient, dosage form, indication and monitoring plan before comparing services. Evidence for one formulation should not be transferred to a different oral, nasal or injectable product simply because ketamine appears in both descriptions.

Sources: CDC — Ketamine and esketamine facts (2026)

Sources and editorial notes

Prepared by DrugRX using the references linked below. Sources were consulted on 2026-10-31. This page has not been independently reviewed by a clinician. Research findings, medication approval and legal permission are separate questions.

  1. CDC — Ketamine and esketamine facts (2026)
  2. DEA — Controlled substances alphabetical list (October 2026)
  3. DailyMed — Ketamine injection product label
  4. Drugs.com — ketamine price guide

Legal information is a dated U.S. reference. Product rules and local laws may change. Where the evidence does not establish a dose, interaction profile or price, the page states that limitation.